Trial Outcomes & Findings for Philips Intracardiac Echocardiography (ICE) Clinical Registry (NCT NCT04950192)

NCT ID: NCT04950192

Last Updated: 2025-01-06

Results Overview

Investigator's assessment (Y/N) on successful delivery of VeriSight to the target intracardiac position and sustained device operation during the procedure

Recruitment status

COMPLETED

Target enrollment

155 participants

Primary outcome timeframe

During procedure

Results posted on

2025-01-06

Participant Flow

Participant milestones

Participant milestones
Measure
Prospective Observational
Prospective observational subjects undergoing planned cardiac procedures utilizing image guidance ICE Image guidance: ICE image guidance will be used on all patients undergoing planned cardiac catheterization procedures
Overall Study
STARTED
155
Overall Study
COMPLETED
155
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Philips Intracardiac Echocardiography (ICE) Clinical Registry

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Prospective Observational
n=155 Participants
Prospective observational subjects undergoing planned cardiac procedures utilizing image guidance ICE Image guidance: ICE image guidance will be used on all patients undergoing planned cardiac catheterization procedures
Age, Categorical
<=18 years
0 Participants
n=99 Participants
Age, Categorical
Between 18 and 65 years
52 Participants
n=99 Participants
Age, Categorical
>=65 years
103 Participants
n=99 Participants
Age, Continuous
68.1 years
STANDARD_DEVIATION 14.9 • n=99 Participants
Sex: Female, Male
Female
67 Participants
n=99 Participants
Sex: Female, Male
Male
88 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
125 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
23 Participants
n=99 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
Race (NIH/OMB)
Asian
3 Participants
n=99 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
Race (NIH/OMB)
Black or African American
5 Participants
n=99 Participants
Race (NIH/OMB)
White
112 Participants
n=99 Participants
Race (NIH/OMB)
More than one race
3 Participants
n=99 Participants
Race (NIH/OMB)
Unknown or Not Reported
32 Participants
n=99 Participants
Region of Enrollment
United States
155 Participants
n=99 Participants

PRIMARY outcome

Timeframe: During procedure

Investigator's assessment (Y/N) on successful delivery of VeriSight to the target intracardiac position and sustained device operation during the procedure

Outcome measures

Outcome measures
Measure
Prospective Observational
n=155 Participants
Prospective observational subjects undergoing planned cardiac procedures utilizing image guidance ICE Image guidance: ICE image guidance will be used on all patients undergoing planned cardiac catheterization procedures
Technical Success
153 Participants

PRIMARY outcome

Timeframe: During procedure

Adequate image quality via Likert scale ( Acceptable or better) as determined by the investigator

Outcome measures

Outcome measures
Measure
Prospective Observational
n=155 Participants
Prospective observational subjects undergoing planned cardiac procedures utilizing image guidance ICE Image guidance: ICE image guidance will be used on all patients undergoing planned cardiac catheterization procedures
Imaging Success
147 Participants

PRIMARY outcome

Timeframe: During procedure

Investigator's assessment (Y/N) on adequacy of VeriSight imaging for visualization of major cardiac structures, and guiding procedural intervention, and ability to detect/ assess intra-procedural complications.

Outcome measures

Outcome measures
Measure
Prospective Observational
n=155 Participants
Prospective observational subjects undergoing planned cardiac procedures utilizing image guidance ICE Image guidance: ICE image guidance will be used on all patients undergoing planned cardiac catheterization procedures
Clinical Success
149 Participants

PRIMARY outcome

Timeframe: Procedure through 48 hours or discharge, whichever is earlier

Detect device-related adverse events periprocedural through discharge or ≤48 hours post-procedure, whichever is earlier.

Outcome measures

Outcome measures
Measure
Prospective Observational
n=155 Participants
Prospective observational subjects undergoing planned cardiac procedures utilizing image guidance ICE Image guidance: ICE image guidance will be used on all patients undergoing planned cardiac catheterization procedures
Number of Participants With Device-related Adverse Event Detection
0 Participants

Adverse Events

Prospective Observational

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Rashmi Ram, Director of Clinical Development

Philips IGTD

Phone: 719-464-6326

Results disclosure agreements

  • Principal investigator is a sponsor employee No publication or presentation concerning a single site experience may be permitted until the multi-center study has been published. Notwithstanding the foregoing or in the event such multicenter publication is not submitted within twelve (12) months of completion of the Study at all sites or if Sponsor confirms there will be no multicenter publication, Principal Investigator shall furnish Sponsor with a copy of any proposed publication or presentation at least forty-five (45) days
  • Publication restrictions are in place

Restriction type: OTHER